The Supreme Court of Canada has determined that British Columbia can initiate a class action on behalf of various Canadian governments against opioid-related harm. This decision endorses the constitutionality of BC’s multi-crown litigation provision under the Opioid Damages and Health Care Costs Recovery Act of 2018.
Due to the opioid crisis, BC enacted this legislation to allow collective legal action against opioid manufacturers and distributors for fostering public health issues. Notably, Section 11 lets BC represent other governments, provided they do not opt-out, in a class action to recover healthcare and related costs.
Pharmaceutical defendants contended that this infringed upon BC’s jurisdiction, asserting that it compromised other provinces’ litigation autonomy and sovereignty because decisions could bind them. However, the Supreme Court concluded that section 11 serves as a procedural instrument without impinging on other provinces’ legislative authority, as it facilitates inter-provincial cooperation in addressing shared national concerns like the opioid epidemic.
The ruling sets a precedent for how provinces can collaborate on national class actions that transcend regional borders. This cooperative framework draws on Justice Karakatsanis’s emphasis on intergovernmental collaboration amid overlapping constitutional responsibilities. The ongoing opioid crisis exemplifies the necessity for such collective approaches.
The class action now awaits certification, potentially advancing as a civil trial in the BC Supreme Court. The case draws parallels to previous BC legislative efforts, including its landmark litigation against tobacco companies in 2000. That litigation led to proposed settlements of $32.5 billion in 2024, setting a precedent for similar cases. The decision to uphold BC’s legislative approach could significantly impact the trajectory of the opioid class action and healthcare cost recovery in Canada.
For further details, review the full JURIST article.